Boston Scientific to acquire Penumbra for $14.5B [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
Boston Scientific plans to acquire Penumbra for about $14.5 billion , the companies announced Thursday. Penumbra makes heart devices to remove clots from blood vessels, treating conditions including pulmonary embolism, stroke and deep vein thrombosis. It also makes an embolization system, designed to stop blood flow to control bleeding. Boston Scientific CEO Mike Mahoney sees an “opportunity to enter new, fast-growing segments within the vascular space,” he said in a statement. The planned purchase, one of the first large medtech acquisitions of 2026, is expected to complement Boston Scientific's portfolio. Buying Penumbra would let Boston Scientific expand into new markets in thrombectomy and embolization, bringing the cardiovascular device company a growth asset, BTIG analyst Ryan Zimmerman wrote in a research note. Boston Scientific will pay $374 per share in cash and stock. Zimmerman said the price is fair, valuing Penumbra at about 19% above its share price Wednesday.
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PENPR Newswire
- Penumbra (PEN) Climbs to All-Time High on $14.5-Billion Merger [Yahoo! Finance]Yahoo! Finance
- Down 6.3% in 4 Weeks, Here's Why Boston Scientific (BSX) Looks Ripe for a Turnaround [Yahoo! Finance]Yahoo! Finance
- How Low Can Boston Scientific Stock Go When Markets Turn Sour? [Forbes]Forbes
- Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 1/15/26 - Form 8-K
- 1/15/26 - Form 8-K
- 12/8/25 - Form 3
- BSX's page on the SEC website